Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€13.36
Target price
23.01.22
€100.00
Performance (%)
-77.10%
End price
24.01.22
€3.06
Summary
This prediction ended on 24.01.22 with a price of €3.06. The BUY prediction by Maxi_Scalibusa for Eledon Pharmaceuticals Inc. performed very badly with a performance of -77.10%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eledon Pharmaceuticals Inc. | -1.235% | -1.235% | 3.226% | 175.862% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Novus Therapeutics Inc. diskutieren
Buy mit Kursziel 100,0
In the thread Trading Novus Therapeutics Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten


